Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlloRx Stem Cells for Pitt Hopkins Syndrome
NCT05165017Phase 2Unknown
- Sponsor
- Vitro Biopharma
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Mesenchymal Stem Cells
01
Overview
A Phase 2 trial of AlloRx Stem Cells in Pitt-Hopkins syndrome (PTHS), sponsored by Vitro Biopharma. Status: unknown.
02
Drugs
AlloRx Stem Cells
03
Conditions
Pitt-Hopkins syndrome (PTHS)
Beyond the preview
Go deeper on NCT05165017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05165017.